Intrinsic Value of S&P & Nasdaq Contact Us

Teleflex Incorporated TFX NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
48/100
2/7 Pass
SharesGrow Intrinsic Value
$142.15
+13.5%
Analyst Price Target
$133.25
+6.4%

Teleflex Incorporated (TFX) is a publicly traded company in the Healthcare sector, operating within the Medical - Instruments & Supplies industry. The company is headquartered in Wayne, PA, United States. The current CEO is Stuart A. Randle.

TFX has IPO date of 1980-03-17, 14,100 full-time employees, listed on the NYSE, a market capitalization of $5.53B.

About Teleflex Incorporated

Teleflex Incorporated is a global medical device manufacturer specializing in single-use devices for critical care, surgical, and interventional procedures. The company's product portfolio spans vascular access solutions under the Arrow brand, interventional cardiology and radiology devices, anesthesia and airway management products, surgical instruments for laparoscopic procedures, and urology solutions including the UroLift System for benign prostatic hyperplasia treatment. Teleflex serves hospitals, healthcare providers, medical device manufacturers, and home care markets worldwide through its comprehensive range of diagnostic and therapeutic devices. Founded in 1943 and headquartered in Wayne, Pennsylvania, the company is a leading supplier of medical devices supporting critical care, surgical, and interventional applications across multiple clinical specialties.

📍 550 East Swedesford Road, Wayne, PA 19087-1603 📞 610 225 6800
Company Details
SectorHealthcare
IndustryMedical - Instruments & Supplies
CountryUnited States
ExchangeNYSE
CurrencyUSD
IPO Date1980-03-17
CEOStuart A. Randle
Employees14,100
Trading Info
Current Price$125.21
Market Cap$5.53B
52-Week Range100.18-138.93
Beta0.84
ETFNo
ADRNo
CUSIP879369106
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message